Translational Oncology · 2013 · 91 citations · 54 references
DysbiosisMicrobial PathogensApoptosisImmunologyGastroenterologyPathologyImmune RegulationCell DeathInnate ImmunityImmune SystemTumor BiologyInflammationBystander EffectIntestinal Commensal BacteriaUlcerative ColitisImmune SurveillanceColon MacrophagesPolarizes Colon MacrophagesHost-microbe InteractionCell BiologyCytokineMucosal ImmunologyImmune Cell DevelopmentPathogenesisGut BarrierMedicine
Intestinal commensal bacteria have recently been shown to trigger macrophages to produce diffusible clastogens (or chromosome-breaking factors) through a bystander effect (BSE) that mediates DNA damage and induces chromosomal instability in neighboring cells. Colon macrophages appear central to colon carcinogenesis and BSE through the expression of tumor necrosis factor-α (TNF-α) and cyclooxygenase-2 (COX-2). The former induces netrin-1, a regulator of intestinal epithelial cell apoptosis, and the latter generates trans-4-hydroxy-2-nonenal (4-HNE), an endogenous mutagen. To test whether colon macrophages are key effectors for BSE, we depleted these cells in interleukin-10 knockout mice colonized with Enterococcus faecalis using encapsulated liposomal clodronate (ELC), a bisphosphonate that causes macrophage apoptosis. We observed that E. faecalis polarizes colon macrophages to an M1 phenotype. In addition, depleting these cells suppressed COX-2 and TNF-α, blocked the formation of 4-HNE protein adducts, and inhibited up-regulation of netrin-1-all markers for BSE. Finally, treatment with ELC prevented colitis, β-catenin activation, and cancer formation. These results show that selected human commensals can polarize colon macrophages to the M1 phenotype and, when activated, serve as the key effector for bacterial-induced BSE. Our findings suggest that depleting M1-polarized macro-phages is a mechanism for the chemopreventive activity of bisphosphonates and that it represents a new strategy for preventing colon cancer induced by intestinal commensals.
54
Interleukin-10-deficient mice develop chronic enterocolitis
Ralf Kühn, Jürgen Löhler, D Rennick et al. · Cell · 1993 · 4.3K citations
Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota
Janelle C. Arthur, Ernesto Peréz-Chanona, Marcus Mühlbauer et al. · Science · 2012 · 2.2K citations · Full text
Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth
Sergei I. Grivennikov, Kepeng Wang, Daniel Mucida et al. · Nature · 2012 · 1.3K citations · Full text
Cytokine, Medicine, Immunology +9
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
Monica M. Bertagnolli, Craig Eagle, Ann G. Zauber et al. · New England Journal of Medicine · 2006 · 1K citations · Full text